Medtech Insights

The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy devices…

The European market for peripheral vascular devices is a dynamic market that will grow steadily through 2028, driven by the availability of new products backed by clinical data. However, market…

The European market for PV devices is evolving, and new product launches backed by clinical evidence will allow for significant expansion through 2027. This Medtech 360 Report provides…

The European market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2026. This…

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2027. This …

The US market for TEO devices is dynamic and complex, driven by continual device improvement and adoption of new, innovative products. This Medtech 360 Report provides comprehensive data and…

The US market for vascular access devices is mature and will contract slightly over the forecast period. Rising unit sales, driven by an increasing patient pool in the US, will be offset by strong…

The European market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2026. This…

The Asia Pacific PV device market will grow through 2026, due in large part to the expanding PAD population in the region as well as increasing awareness of treatment options. However, significant…

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2026. This …

The Asia Pacific PV device market will grow through 2026, due in large part to the expanding PAD population in the region as well as increasing awareness of treatment options. However, significant…

The Japanese PV device market will see modest growth through 2026, driven by endovascular procedure volume growth and rising PVD diagnosis rates. The  approval of premium-priced DCBs and…